PMC:7096774
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
---|---|---|---|---|---|---|
1 | 42-62 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 | |
6 | 634-639 | Gene | denotes | spike | Gene:43740568 | |
7 | 357-367 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
8 | 150-169 | Disease | denotes | coronavirus disease | MESH:D018352 | |
9 | 171-179 | Disease | denotes | COVID-19 | MESH:C000657245 | |
16 | 772-819 | Species | denotes | Severe acute respiratory syndrome coronavirus 2 | Tax:2697049 | |
17 | 821-831 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
18 | 900-910 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
19 | 685-694 | Disease | denotes | pneumonia | MESH:D011014 | |
20 | 929-948 | Disease | denotes | coronavirus disease | MESH:D018352 | |
21 | 950-958 | Disease | denotes | COVID-19 | MESH:C000657245 | |
25 | 1167-1177 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
26 | 1296-1306 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
27 | 1061-1069 | Disease | denotes | COVID-19 | MESH:C000657245 | |
41 | 2440-2444 | Gene | denotes | RdRp | Gene:43740578 | |
42 | 2468-2469 | Gene | denotes | N | Gene:43740575 | |
43 | 2402-2403 | Gene | denotes | E | Gene:43740570 | |
44 | 2302-2305 | Gene | denotes | THL | Gene:7062 | |
45 | 1574-1582 | Disease | denotes | COVID-19 | MESH:C000657245 | |
46 | 1766-1772 | Disease | denotes | nausea | MESH:D009325 | |
47 | 1804-1809 | Disease | denotes | fever | MESH:D005334 | |
48 | 1819-1827 | Disease | denotes | weakness | MESH:D018908 | |
49 | 1832-1837 | Disease | denotes | cough | MESH:D003371 | |
50 | 1895-1903 | Disease | denotes | COVID-19 | MESH:C000657245 | |
51 | 2064-2084 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 | |
52 | 2097-2117 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 | |
53 | 2222-2228 | Disease | denotes | HUSLAB | ||
55 | 2644-2652 | Disease | denotes | COVID-19 | MESH:C000657245 | |
57 | 2711-2730 | Disease | denotes | coronavirus disease | MESH:D018352 | |
67 | 2898-2902 | Gene | denotes | RdRp | Gene:43740578 | |
68 | 2895-2896 | Gene | denotes | E | Gene:43740570 | |
69 | 2904-2905 | Gene | denotes | N | Gene:43740575 | |
70 | 2938-2949 | Disease | denotes | NPS HUSTHL | MESH:D009261 | |
71 | 3071-3082 | Disease | denotes | NPS HUSTHL | MESH:D009261 | |
72 | 3206-3241 | Disease | denotes | NPS HUSTHL NegNeg NegNeg NegNeg | MESH:D009261 | |
73 | 3309-3344 | Disease | denotes | NPS HUSTHL NegNeg NegNeg NegNeg | MESH:D009261 | |
74 | 3364-3378 | Disease | denotes | ND ND ND ND | MESH:C537849 | |
75 | 3473-3508 | Disease | denotes | NPS HUSTHL NegNeg NegNeg NegNeg | MESH:D009261 | |
77 | 2776-2796 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 | |
84 | 3524-3540 | Gene | denotes | envelope protein | Gene:64006 | |
85 | 3804-3808 | Gene | denotes | RdRp | Gene:43740578 | |
86 | 3521-3522 | Gene | denotes | E | Gene:43740570 | |
87 | 3669-3670 | Gene | denotes | N | Gene:43740575 | |
88 | 3880-3883 | Gene | denotes | THL | Gene:7062 | |
89 | 3547-3550 | Disease | denotes | HUS | MESH:D006463 | |
91 | 4814-4824 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
105 | 4860-4870 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
106 | 4877-4887 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
107 | 5136-5139 | Chemical | denotes | CO2 | MESH:D002245 | |
108 | 5166-5198 | Chemical | denotes | Eagle's minimum essential medium | ||
109 | 5200-5204 | Chemical | denotes | EMEM | ||
110 | 5263-5273 | Chemical | denotes | penicillin | MESH:D010406 | |
111 | 5284-5296 | Chemical | denotes | streptomycin | MESH:D013307 | |
112 | 5303-5314 | Chemical | denotes | L-glutamine | MESH:D005973 | |
113 | 5322-5327 | Chemical | denotes | HEPES | MESH:D006531 | |
114 | 5247-5250 | Disease | denotes | FBS | MESH:D005198 | |
115 | 4966-4968 | CellLine | denotes | E6 | CVCL:4582 | |
116 | 5443-5445 | CellLine | denotes | E6 | CVCL:4582 | |
117 | 5681-5683 | CellLine | denotes | E6 | CVCL:4582 | |
119 | 5991-6001 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
126 | 6078-6088 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
127 | 6457-6466 | Chemical | denotes | histidine | MESH:D006639 | |
128 | 6470-6478 | Chemical | denotes | tyrosine | MESH:D014443 | |
129 | 6286-6288 | CellLine | denotes | E6 | CVCL:4582 | |
130 | 6328-6335 | Mutation | denotes | C21707T | g.21707C>T | |
131 | 6480-6484 | Mutation | denotes | H49Y | p.H49Y | |
133 | 6586-6601 | Disease | denotes | CoV-2 infection | MESH:C000657245 | |
143 | 6769-6779 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
144 | 6882-6889 | Species | denotes | patient | Tax:9606 | |
145 | 6900-6910 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
146 | 7194-7199 | Species | denotes | human | Tax:9606 | |
147 | 6986-6993 | Chemical | denotes | acetone | MESH:D000096 | |
148 | 7144-7170 | Chemical | denotes | fluorescein isothiocyanate | ||
149 | 7172-7176 | Chemical | denotes | FITC | ||
150 | 6851-6859 | Disease | denotes | infected | MESH:D007239 | |
151 | 6842-6844 | CellLine | denotes | E6 | CVCL:4582 | |
153 | 7600-7608 | Disease | denotes | COVID-19 | MESH:C000657245 | |
155 | 7662-7686 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 | |
157 | 7693-7703 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
166 | 8352-8353 | Gene | denotes | N | Gene:43740575 | |
167 | 8355-8356 | Gene | denotes | S | Gene:43740568 | |
168 | 8095-8104 | Species | denotes | SARS-CoV2 | Tax:2697049 | |
169 | 8342-8351 | Species | denotes | SARS-CoV2 | Tax:2697049 | |
170 | 8176-8197 | Chemical | denotes | Laemmli sample buffer | ||
171 | 8105-8113 | Disease | denotes | infected | MESH:D007239 | |
172 | 8152-8161 | Disease | denotes | infection | MESH:D007239 | |
173 | 8119-8121 | CellLine | denotes | E6 | CVCL:4582 | |
177 | 8554-8561 | Species | denotes | patient | Tax:9606 | |
178 | 8514-8533 | Disease | denotes | SARS-CoV-2 infected | MESH:C000657245 | |
179 | 8539-8541 | CellLine | denotes | E6 | CVCL:4582 | |
188 | 9225-9228 | Gene | denotes | Rad | Gene:6236 | |
189 | 8690-8691 | Gene | denotes | S | Gene:43740568 | |
190 | 8938-8948 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
191 | 9003-9013 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
192 | 9064-9072 | Species | denotes | SARS-CoV | Tax:694009 | |
193 | 8803-8810 | Species | denotes | patient | Tax:9606 | |
194 | 9317-9322 | Species | denotes | human | Tax:9606 | |
195 | 9051-9053 | CellLine | denotes | E6 | CVCL:4582 | |
203 | 9361-9371 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
204 | 9693-9703 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
205 | 9586-9590 | Chemical | denotes | EMEM | ||
206 | 9932-9935 | Chemical | denotes | CO2 | MESH:D002245 | |
207 | 9632-9635 | Disease | denotes | FBS | MESH:D005198 | |
208 | 10073-10088 | Disease | denotes | CoV-2 infection | MESH:C000657245 | |
209 | 9797-9799 | CellLine | denotes | E6 | CVCL:4582 | |
212 | 10327-10334 | Species | denotes | patient | Tax:9606 | |
213 | 10270-10279 | Disease | denotes | infection | MESH:D007239 | |
218 | 10760-10763 | Gene | denotes | IgG | ||
219 | 10772-10794 | Species | denotes | human coronavirus OC43 | Tax:31631 | |
220 | 10850-10858 | Species | denotes | SARS-CoV | Tax:694009 | |
221 | 10799-10803 | Species | denotes | 229E | Tax:11137 | |
223 | 11048-11063 | Gene | denotes | Directive 95/46 | ||
227 | 11325-11332 | Species | denotes | patient | Tax:9606 | |
228 | 11355-11365 | Chemical | denotes | TYH2018322 | ||
229 | 11367-11377 | Chemical | denotes | TYH2019263 | ||
238 | 12191-12194 | Gene | denotes | THL | Gene:7062 | |
239 | 11762-11770 | Disease | denotes | COVID-19 | MESH:C000657245 | |
240 | 12001-12010 | Disease | denotes | pneumonia | MESH:D011014 | |
241 | 12024-12030 | Disease | denotes | nausea | MESH:D009325 | |
242 | 12032-12042 | Disease | denotes | high fever | MESH:D005334 | |
243 | 12044-12049 | Disease | denotes | cough | MESH:D003371 | |
244 | 12051-12068 | Disease | denotes | muscular weakness | MESH:D018908 | |
245 | 12073-12080 | Disease | denotes | fatigue | MESH:D005221 | |
249 | 12262-12270 | Disease | denotes | COVID-19 | MESH:C000657245 | |
250 | 12501-12509 | Disease | denotes | COVID-19 | MESH:C000657245 | |
251 | 12510-12519 | Disease | denotes | infection | MESH:D007239 | |
254 | 12731-12738 | Species | denotes | patient | Tax:9606 | |
255 | 12966-12970 | Species | denotes | ncov | Tax:2697049 | |
260 | 13123-13131 | Species | denotes | patients | Tax:9606 | |
261 | 13256-13266 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
262 | 13043-13051 | Disease | denotes | COVID-19 | MESH:C000657245 | |
263 | 13459-13479 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 | |
266 | 14019-14027 | Species | denotes | patients | Tax:9606 | |
267 | 14095-14103 | Species | denotes | SARS-CoV | Tax:694009 | |
272 | 14587-14588 | Gene | denotes | S | Gene:43740568 | |
273 | 14300-14301 | Gene | denotes | N | Gene:43740575 | |
274 | 14306-14307 | Gene | denotes | S | Gene:43740568 | |
275 | 14409-14416 | Species | denotes | patient | Tax:9606 | |
289 | 14857-14866 | Species | denotes | hCoV OC43 | Tax:31631 | |
290 | 14910-14918 | Species | denotes | SARS-CoV | Tax:694009 | |
291 | 14943-14953 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
292 | 15489-15499 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
293 | 15641-15649 | Species | denotes | patients | Tax:9606 | |
294 | 15934-15942 | Species | denotes | patients | Tax:9606 | |
295 | 16059-16067 | Species | denotes | patients | Tax:9606 | |
296 | 14871-14875 | Species | denotes | 229E | Tax:11137 | |
297 | 15344-15354 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
298 | 15761-15769 | Species | denotes | patients | Tax:9606 | |
299 | 14812-14841 | Disease | denotes | coronavirus (hCoV) infections | MESH:D018352 | |
300 | 15655-15673 | Disease | denotes | SARS-CoV infection | MESH:C000657245 | |
301 | 16104-16124 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 | |
313 | 16440-16484 | Species | denotes | Middle East respiratory syndrome coronavirus | Tax:1335626 | |
314 | 16576-16584 | Species | denotes | SARS-CoV | Tax:694009 | |
315 | 16601-16606 | Species | denotes | human | Tax:9606 | |
316 | 16774-16782 | Species | denotes | patients | Tax:9606 | |
317 | 16952-16961 | Species | denotes | HCoV-229E | Tax:11137 | |
318 | 16966-16975 | Species | denotes | HCoV-OC43 | Tax:31631 | |
319 | 17019-17027 | Species | denotes | children | Tax:9606 | |
320 | 17108-17117 | Species | denotes | HCoV-NL63 | Tax:277944 | |
321 | 17122-17131 | Species | denotes | HCoV-229E | Tax:11137 | |
322 | 16263-16273 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
323 | 16814-16818 | Species | denotes | HCoV | Tax:694448 | |
327 | 17208-17216 | Species | denotes | patients | Tax:9606 | |
328 | 17371-17391 | Disease | denotes | SARS CoV-2 infection | MESH:C000657245 | |
329 | 17603-17624 | Disease | denotes | SARS-CoV-2 infections | MESH:C000657245 | |
331 | 18465-18468 | Gene | denotes | THL | Gene:7062 | |
334 | 18767-18769 | Disease | denotes | AH | MESH:D007039 | |
335 | 18844-18852 | Disease | denotes | COVID-19 | MESH:C000657245 | |
338 | 19206-19209 | Gene | denotes | THL | Gene:7062 | |
339 | 19150-19160 | Species | denotes | SARS-CoV-2 | Tax:2697049 | |
343 | 19293-19296 | Gene | denotes | THL | Gene:7062 | |
344 | 19245-19248 | Gene | denotes | THL | Gene:7062 | |
345 | 19249-19257 | Disease | denotes | COVID-19 | MESH:C000657245 | |
347 | 19363-19366 | Gene | denotes | THL | Gene:7062 | |
350 | 19461-19464 | Gene | denotes | THL | Gene:7062 | |
351 | 19512-19520 | Disease | denotes | COVID-19 | MESH:C000657245 | |
359 | 19876-19879 | Gene | denotes | THL | Gene:7062 | |
360 | 19721-19729 | Disease | denotes | COVID-19 | MESH:C000657245 | |
361 | 19744-19750 | Disease | denotes | HUSLAB | ||
362 | 19806-19812 | Disease | denotes | HUSLAB | ||
363 | 19866-19872 | Disease | denotes | HUSLAB | ||
364 | 19671-19673 | CellLine | denotes | LM | CVCL:5998 | |
365 | 19760-19762 | CellLine | denotes | LM | CVCL:5998 | |
367 | 19920-19927 | Species | denotes | patient | Tax:9606 | |
369 | 19941-19943 | Disease | denotes | MJ | MESH:D009207 | |
371 | 20078-20084 | Disease | denotes | HUSLAB | ||
378 | 20207-20210 | Gene | denotes | CSK | Gene:1445 | |
379 | 20380-20383 | Gene | denotes | CSK | Gene:1445 | |
380 | 20343-20346 | Gene | denotes | THL | Gene:7062 | |
381 | 20231-20234 | Gene | denotes | THL | Gene:7062 | |
382 | 20262-20270 | Disease | denotes | COVID-19 | MESH:C000657245 | |
383 | 20299-20307 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 414-420 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T2 | 438-448 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T3 | 511-519 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T4 | 572-575 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T5 | 580-583 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T6 | 640-648 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T7 | 1329-1337 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T8 | 1357-1362 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T9 | 1440-1445 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T10 | 1743-1747 | Body_part | denotes | nose | http://purl.org/sig/ont/fma/fma46472 |
T11 | 2410-2413 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T12 | 2424-2427 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T13 | 2911-2914 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T14 | 2916-2919 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T15 | 3133-3138 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T16 | 3254-3259 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T17 | 3357-3362 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T18 | 3412-3417 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T19 | 3533-3540 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T20 | 3541-3545 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
T21 | 3593-3596 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T22 | 3598-3614 | Body_part | denotes | immunoglobulin G | http://purl.org/sig/ont/fma/fma62872 |
T23 | 3616-3619 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T24 | 3621-3637 | Body_part | denotes | immunoglobulin M | http://purl.org/sig/ont/fma/fma62873 |
T25 | 3685-3692 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T26 | 3693-3697 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
T27 | 3810-3813 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T28 | 3824-3827 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T29 | 3839-3843 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
T30 | 4969-4974 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T31 | 5106-5111 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T32 | 5240-5245 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T33 | 5305-5314 | Body_part | denotes | glutamine | http://purl.org/sig/ont/fma/fma82752 |
T34 | 5446-5451 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T35 | 5684-5689 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T36 | 6023-6029 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T37 | 6289-6294 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T38 | 6457-6466 | Body_part | denotes | histidine | http://purl.org/sig/ont/fma/fma82755 |
T39 | 6470-6478 | Body_part | denotes | tyrosine | http://purl.org/sig/ont/fma/fma82768 |
T40 | 6537-6549 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T41 | 6552-6560 | Body_part | denotes | Antibody | http://purl.org/sig/ont/fma/fma62871 |
T42 | 6602-6607 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T43 | 6732-6737 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T44 | 6738-6741 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T45 | 6746-6749 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T46 | 6845-6850 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T47 | 7006-7011 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T48 | 7088-7091 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T49 | 7107-7110 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T50 | 7112-7122 | Body_part | denotes | Antibodies | http://purl.org/sig/ont/fma/fma62871 |
T51 | 7200-7203 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T52 | 7207-7210 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T53 | 7296-7299 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T54 | 7332-7335 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T55 | 7404-7409 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T56 | 7585-7590 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T57 | 7704-7707 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T58 | 7712-7715 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T59 | 7834-7837 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T60 | 7842-7845 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T61 | 8013-8016 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T62 | 8021-8024 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T63 | 8078-8083 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T64 | 8122-8127 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T65 | 8315-8320 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T66 | 8363-8370 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T67 | 8451-8456 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T68 | 8542-8547 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T69 | 8562-8567 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T70 | 8664-8671 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T71 | 8811-8816 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T72 | 8949-8957 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T73 | 9014-9022 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T74 | 9073-9081 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T75 | 9394-9402 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T76 | 9481-9486 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T77 | 9744-9749 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T78 | 9800-9805 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T79 | 9845-9850 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T80 | 10043-10048 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T81 | 10119-10124 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T82 | 10137-10142 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T83 | 10454-10459 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T84 | 10521-10526 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T85 | 10536-10541 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T86 | 10629-10634 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T87 | 10760-10763 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T88 | 10833-10841 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T89 | 10861-10868 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T90 | 11252-11257 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T91 | 11448-11453 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T92 | 11636-11641 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T93 | 12018-12022 | Body_part | denotes | nose | http://purl.org/sig/ont/fma/fma46472 |
T94 | 12717-12723 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T95 | 13104-13109 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T96 | 13318-13323 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T97 | 13362-13367 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T98 | 13433-13441 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T99 | 13731-13734 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T100 | 13739-13742 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T101 | 14163-14166 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T102 | 14171-14174 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T103 | 14220-14225 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T104 | 14308-14315 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T105 | 14380-14388 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T106 | 14417-14422 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T107 | 14456-14463 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T108 | 14492-14500 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T109 | 14557-14565 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T110 | 14589-14596 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T111 | 15238-15246 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T112 | 15774-15777 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T113 | 15810-15813 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
T114 | 15818-15821 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
T115 | 16900-16905 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T116 | 18994-19000 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
T117 | 19590-19595 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T118 | 19650-19655 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T119 | 20184-20189 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1357-1362 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T2 | 1440-1445 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T3 | 1743-1747 | Body_part | denotes | nose | http://purl.obolibrary.org/obo/UBERON_0000004 |
T4 | 3133-3138 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T5 | 3254-3259 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T6 | 3357-3362 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T7 | 3412-3417 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T8 | 5240-5245 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T9 | 6602-6607 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T10 | 6732-6737 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T11 | 7006-7011 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T12 | 7404-7409 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T13 | 7585-7590 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T14 | 8078-8083 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T15 | 8315-8320 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T16 | 8451-8456 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T17 | 8562-8567 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T18 | 8811-8816 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T19 | 9481-9486 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T20 | 9744-9749 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T21 | 9845-9850 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T22 | 10043-10048 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T23 | 10137-10142 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T24 | 10454-10459 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T25 | 10536-10541 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T26 | 10629-10634 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T27 | 11252-11257 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T28 | 11448-11453 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T29 | 11636-11641 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T30 | 12018-12022 | Body_part | denotes | nose | http://purl.obolibrary.org/obo/UBERON_0000004 |
T31 | 13104-13109 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T32 | 13318-13323 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T33 | 13362-13367 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T34 | 14220-14225 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T35 | 14417-14422 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T36 | 16900-16905 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T37 | 19590-19595 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T38 | 19650-19655 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T39 | 20184-20189 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 42-50 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 53-62 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T3 | 171-179 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 357-365 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 685-694 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T6 | 772-819 | Disease | denotes | Severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 821-829 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 900-908 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 950-958 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 1061-1069 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 1167-1175 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 1296-1304 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 1574-1582 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 1737-1747 | Disease | denotes | runny nose | http://purl.obolibrary.org/obo/MONDO_0003014 |
T15 | 1895-1903 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T16 | 2064-2072 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T17 | 2075-2084 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T18 | 2097-2105 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T19 | 2108-2117 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T20 | 2644-2652 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T21 | 2701-2709 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T22 | 2776-2784 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T23 | 2787-2796 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T24 | 2938-2941 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T25 | 3071-3074 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T26 | 3206-3209 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T27 | 3309-3312 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T28 | 3473-3476 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T29 | 3547-3550 | Disease | denotes | HUS | http://purl.obolibrary.org/obo/MONDO_0001549 |
T30 | 3778-3781 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T31 | 4814-4822 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T32 | 4860-4868 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T33 | 4877-4885 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T34 | 5011-5014 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T35 | 5936-5939 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T36 | 5991-5999 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T37 | 6078-6086 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T38 | 6149-6152 | Disease | denotes | NPS | http://purl.obolibrary.org/obo/MONDO_0008061 |
T39 | 6581-6589 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T40 | 6592-6601 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T41 | 6769-6777 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T42 | 6900-6908 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T43 | 7600-7608 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T44 | 7652-7660 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T45 | 7662-7686 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T46 | 7693-7701 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T47 | 8095-8099 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T48 | 8152-8161 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T49 | 8342-8346 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T50 | 8514-8522 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T51 | 8938-8946 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T52 | 9003-9011 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T53 | 9064-9072 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T54 | 9361-9369 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T55 | 9693-9701 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T56 | 10068-10076 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T57 | 10079-10088 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T58 | 10270-10279 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T59 | 10850-10858 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T60 | 11762-11770 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T61 | 12001-12010 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T62 | 12012-12022 | Disease | denotes | runny nose | http://purl.obolibrary.org/obo/MONDO_0003014 |
T63 | 12262-12270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T64 | 12501-12509 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T65 | 12510-12519 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T66 | 13043-13051 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T67 | 13256-13264 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T68 | 13459-13467 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T69 | 13470-13479 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T70 | 14095-14103 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T71 | 14831-14841 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T72 | 14910-14918 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T73 | 14943-14951 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T74 | 15344-15352 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T75 | 15489-15497 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T76 | 15655-15673 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T77 | 15664-15673 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T78 | 16104-16112 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T79 | 16115-16124 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T80 | 16263-16271 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T81 | 16576-16584 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T82 | 16769-16773 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T83 | 17203-17207 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T84 | 17301-17305 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T85 | 17371-17375 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T86 | 17382-17391 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T87 | 17603-17611 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T88 | 17614-17624 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T89 | 18408-18410 | Disease | denotes | LS | http://purl.obolibrary.org/obo/MONDO_0009723 |
T90 | 18844-18852 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T91 | 18971-18973 | Disease | denotes | TS | http://purl.obolibrary.org/obo/MONDO_0010979|http://purl.obolibrary.org/obo/MONDO_0016455 |
T93 | 19150-19158 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T94 | 19249-19257 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T95 | 19512-19520 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T96 | 19540-19542 | Disease | denotes | TS | http://purl.obolibrary.org/obo/MONDO_0010979|http://purl.obolibrary.org/obo/MONDO_0016455 |
T98 | 19671-19673 | Disease | denotes | LM | http://purl.obolibrary.org/obo/MONDO_0016569 |
T99 | 19721-19729 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T100 | 19760-19762 | Disease | denotes | LM | http://purl.obolibrary.org/obo/MONDO_0016569 |
T101 | 19948-19950 | Disease | denotes | LS | http://purl.obolibrary.org/obo/MONDO_0009723 |
T102 | 20262-20270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T103 | 20299-20307 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 383-388 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T2 | 429-430 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 672-673 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 911-916 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T5 | 1603-1604 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 1605-1611 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | female |
T7 | 1662-1664 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T8 | 1735-1736 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 1743-1747 | http://www.ebi.ac.uk/efo/EFO_0000828 | denotes | nose |
T10 | 1776-1778 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T11 | 2361-2368 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T12 | 3541-3545 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
T13 | 3663-3667 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T14 | 3693-3697 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
T15 | 3839-3843 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
T16 | 4023-4029 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T17 | 4762-4764 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T18 | 4840-4845 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T19 | 4871-4876 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T20 | 4919-4920 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T21 | 4961-4974 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T22 | 5106-5111 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T23 | 5438-5451 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T24 | 5534-5535 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T25 | 5617-5622 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T26 | 5645-5646 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T27 | 5651-5656 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T28 | 5676-5689 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T29 | 5695-5700 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T30 | 5739-5744 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | Virus |
T31 | 5800-5805 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T32 | 5979-5981 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T33 | 5986-5988 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
T34 | 6234-6239 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T35 | 6281-6294 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T36 | 6300-6305 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T37 | 6306-6311 | http://purl.obolibrary.org/obo/CLO_0050964 | denotes | had 1 |
T38 | 6455-6456 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T39 | 6837-6850 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T40 | 6926-6931 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T41 | 7194-7199 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T42 | 7860-7861 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T43 | 8114-8127 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T44 | 8279-8283 | http://purl.obolibrary.org/obo/CLO_0001757 | denotes | At 1 |
T45 | 8440-8444 | http://purl.obolibrary.org/obo/CLO_0001757 | denotes | at 1 |
T46 | 8534-8547 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T47 | 8715-8723 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T48 | 8857-8866 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membranes |
T49 | 8963-8972 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | labelling |
T50 | 9046-9050 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
T51 | 9046-9050 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
T52 | 9148-9150 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T53 | 9155-9157 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T54 | 9155-9157 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T55 | 9293-9295 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | LI |
T56 | 9307-9311 | http://purl.obolibrary.org/obo/NCBITaxon_9925 | denotes | goat |
T57 | 9317-9322 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T58 | 9339-9343 | http://purl.obolibrary.org/obo/CLO_0001757 | denotes | at 1 |
T59 | 9449-9453 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T60 | 9457-9458 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T61 | 9792-9805 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T62 | 9839-9844 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T63 | 10119-10124 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T64 | 10238-10242 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T65 | 10521-10526 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T66 | 10586-10592 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T67 | 10608-10612 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T68 | 10622-10628 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T69 | 10713-10719 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T70 | 10772-10777 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T71 | 10822-10832 | http://purl.obolibrary.org/obo/NCBITaxon_10141 | denotes | guinea pig |
T72 | 10898-10903 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T73 | 11064-11066 | http://purl.obolibrary.org/obo/CLO_0002878 | denotes | EC |
T74 | 12018-12022 | http://www.ebi.ac.uk/efo/EFO_0000828 | denotes | nose |
T75 | 12137-12143 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T76 | 13018-13030 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T77 | 13035-13042 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T78 | 13148-13155 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T79 | 13220-13221 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T80 | 13280-13283 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T81 | 13318-13323 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T82 | 13318-13323 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T83 | 13325-13327 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T84 | 13590-13597 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T85 | 13707-13709 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T86 | 14000-14001 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T87 | 14115-14118 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T88 | 14267-14268 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T89 | 14389-14394 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T90 | 14482-14484 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T91 | 14489-14491 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T92 | 14489-14491 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T93 | 14703-14704 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T94 | 14806-14811 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T95 | 14925-14932 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T96 | 14967-14971 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T97 | 14983-14988 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T98 | 15056-15057 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T99 | 15149-15150 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T100 | 15435-15440 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T101 | 15790-15795 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T102 | 16031-16032 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T103 | 16187-16189 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T104 | 16242-16244 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T105 | 16393-16394 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T106 | 16539-16540 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T107 | 16601-16606 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T108 | 17133-17135 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T109 | 17147-17150 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T110 | 17324-17334 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing is |
T111 | 17369-17370 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T112 | 17393-17395 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T113 | 17513-17520 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T114 | 17567-17568 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T115 | 18254-18267 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organisations |
T116 | 18414-18415 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T117 | 18469-18472 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T118 | 18794-18799 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T119 | 19117-19122 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T120 | 19215-19217 | http://purl.obolibrary.org/obo/CLO_0007874 | denotes | MS |
T121 | 19604-19605 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T122 | 19626-19636 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organising |
T123 | 19671-19673 | http://purl.obolibrary.org/obo/CLO_0007336 | denotes | LM |
T124 | 19760-19762 | http://purl.obolibrary.org/obo/CLO_0007336 | denotes | LM |
T125 | 19881-19883 | http://purl.obolibrary.org/obo/PR_000010213 | denotes | MB |
T126 | 19941-19943 | http://purl.obolibrary.org/obo/CLO_0007731 | denotes | MJ |
T127 | 20160-20170 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organising |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 438-448 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T2 | 640-648 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T3 | 1276-1278 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T4 | 2907-2909 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T5 | 2978-2980 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T6 | 2982-2984 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T7 | 2987-2989 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T8 | 3058-3060 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T9 | 3063-3065 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T10 | 3068-3070 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T11 | 3121-3123 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T12 | 3126-3128 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T13 | 3130-3132 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T14 | 3243-3245 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T15 | 3247-3249 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T16 | 3251-3253 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T17 | 3265-3267 | Chemical | denotes | ND | http://purl.obolibrary.org/obo/CHEBI_73419 |
T18 | 3346-3348 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T19 | 3350-3352 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T20 | 3354-3356 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T21 | 3364-3366 | Chemical | denotes | ND | http://purl.obolibrary.org/obo/CHEBI_73419 |
T22 | 3368-3370 | Chemical | denotes | ND | http://purl.obolibrary.org/obo/CHEBI_73419 |
T23 | 3372-3374 | Chemical | denotes | ND | http://purl.obolibrary.org/obo/CHEBI_73419 |
T24 | 3376-3378 | Chemical | denotes | ND | http://purl.obolibrary.org/obo/CHEBI_73419 |
T25 | 3510-3512 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T26 | 3514-3516 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T27 | 3518-3520 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T28 | 3533-3540 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T29 | 3639-3641 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T30 | 3685-3692 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T31 | 3699-3701 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T32 | 3719-3721 | Chemical | denotes | ND | http://purl.obolibrary.org/obo/CHEBI_73419 |
T33 | 5136-5139 | Chemical | denotes | CO2 | http://purl.obolibrary.org/obo/CHEBI_16526 |
T34 | 5263-5273 | Chemical | denotes | penicillin | http://purl.obolibrary.org/obo/CHEBI_17334|http://purl.obolibrary.org/obo/CHEBI_51356 |
T36 | 5284-5296 | Chemical | denotes | streptomycin | http://purl.obolibrary.org/obo/CHEBI_17076|http://purl.obolibrary.org/obo/CHEBI_58007 |
T38 | 5303-5314 | Chemical | denotes | L-glutamine | http://purl.obolibrary.org/obo/CHEBI_18050|http://purl.obolibrary.org/obo/CHEBI_30011|http://purl.obolibrary.org/obo/CHEBI_58359 |
T41 | 5305-5314 | Chemical | denotes | glutamine | http://purl.obolibrary.org/obo/CHEBI_28300 |
T42 | 5322-5327 | Chemical | denotes | HEPES | http://purl.obolibrary.org/obo/CHEBI_46756 |
T43 | 6457-6466 | Chemical | denotes | histidine | http://purl.obolibrary.org/obo/CHEBI_27570 |
T44 | 6470-6478 | Chemical | denotes | tyrosine | http://purl.obolibrary.org/obo/CHEBI_18186 |
T45 | 6537-6549 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T46 | 6986-6993 | Chemical | denotes | acetone | http://purl.obolibrary.org/obo/CHEBI_15347 |
T47 | 7144-7170 | Chemical | denotes | fluorescein isothiocyanate | http://purl.obolibrary.org/obo/CHEBI_37926 |
T48 | 7144-7155 | Chemical | denotes | fluorescein | http://purl.obolibrary.org/obo/CHEBI_31624 |
T49 | 7156-7170 | Chemical | denotes | isothiocyanate | http://purl.obolibrary.org/obo/CHEBI_52221 |
T50 | 7172-7176 | Chemical | denotes | FITC | http://purl.obolibrary.org/obo/CHEBI_37926 |
T51 | 8191-8197 | Chemical | denotes | buffer | http://purl.obolibrary.org/obo/CHEBI_35225 |
T52 | 8363-8370 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T53 | 8664-8671 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T54 | 8682-8691 | Chemical | denotes | Ponceau S | http://purl.obolibrary.org/obo/CHEBI_90319 |
T55 | 8700-8714 | Chemical | denotes | nitrocellulose | http://purl.obolibrary.org/obo/CHEBI_53325 |
T56 | 8949-8957 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T57 | 9014-9022 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T58 | 9073-9081 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T59 | 9155-9157 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T60 | 9293-9295 | Chemical | denotes | LI | http://purl.obolibrary.org/obo/CHEBI_74540 |
T61 | 9446-9448 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T62 | 9640-9651 | Chemical | denotes | antibiotics | http://purl.obolibrary.org/obo/CHEBI_33281 |
T63 | 9864-9871 | Chemical | denotes | mixture | http://purl.obolibrary.org/obo/CHEBI_60004 |
T64 | 9932-9935 | Chemical | denotes | CO2 | http://purl.obolibrary.org/obo/CHEBI_16526 |
T65 | 10235-10237 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T66 | 10605-10607 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T67 | 10861-10868 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T68 | 13267-13279 | Chemical | denotes | nucleic acid | http://purl.obolibrary.org/obo/CHEBI_33696 |
T69 | 13275-13279 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T70 | 13583-13589 | Chemical | denotes | corona | http://purl.obolibrary.org/obo/CHEBI_37409 |
T71 | 13964-13972 | Chemical | denotes | antigens | http://purl.obolibrary.org/obo/CHEBI_59132 |
T72 | 14308-14315 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T73 | 14456-14463 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T74 | 14489-14491 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T75 | 14492-14500 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T76 | 14589-14596 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T77 | 14637-14639 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T78 | 14964-14966 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T79 | 15308-15310 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T80 | 17039-17044 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T81 | 18408-18410 | Chemical | denotes | LS | http://purl.obolibrary.org/obo/CHEBI_73523 |
T82 | 18767-18769 | Chemical | denotes | AH | http://purl.obolibrary.org/obo/CHEBI_73771 |
T83 | 18791-18793 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T84 | 18971-18973 | Chemical | denotes | TS | http://purl.obolibrary.org/obo/CHEBI_73664 |
T85 | 19042-19044 | Chemical | denotes | SK | http://purl.obolibrary.org/obo/CHEBI_144702 |
T86 | 19211-19213 | Chemical | denotes | MP | http://purl.obolibrary.org/obo/CHEBI_73612 |
T87 | 19215-19217 | Chemical | denotes | MS | http://purl.obolibrary.org/obo/CHEBI_73613 |
T88 | 19219-19221 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
T89 | 19279-19284 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T90 | 19305-19307 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
T92 | 19354-19359 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T93 | 19408-19410 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
T94 | 19533-19535 | Chemical | denotes | AK | http://purl.obolibrary.org/obo/CHEBI_132403 |
T95 | 19540-19542 | Chemical | denotes | TS | http://purl.obolibrary.org/obo/CHEBI_73664 |
T96 | 19597-19599 | Chemical | denotes | AK | http://purl.obolibrary.org/obo/CHEBI_132403 |
T97 | 19671-19673 | Chemical | denotes | LM | http://purl.obolibrary.org/obo/CHEBI_73584 |
T98 | 19678-19680 | Chemical | denotes | ML | http://purl.obolibrary.org/obo/CHEBI_74705 |
T99 | 19760-19762 | Chemical | denotes | LM | http://purl.obolibrary.org/obo/CHEBI_73584 |
T100 | 19948-19950 | Chemical | denotes | LS | http://purl.obolibrary.org/obo/CHEBI_73523 |
T101 | 20200-20202 | Chemical | denotes | NI | http://purl.obolibrary.org/obo/CHEBI_141421 |
T102 | 20329-20334 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 3853-3874 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | reverse-transcription |
T2 | 3861-3874 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
T3 | 11007-11017 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | Regulation |
T4 | 11019-11029 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | Regulation |
T5 | 13201-13216 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-121 | Sentence | denotes | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |
T2 | 123-131 | Sentence | denotes | Abstract |
T3 | 132-225 | Sentence | denotes | The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. |
T4 | 226-259 | Sentence | denotes | No secondary cases were detected. |
T5 | 260-352 | Sentence | denotes | We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. |
T6 | 353-497 | Sentence | denotes | The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. |
T7 | 498-649 | Sentence | denotes | Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins. |
T8 | 651-771 | Sentence | denotes | On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China [1]. |
T9 | 772-886 | Sentence | denotes | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was isolated by Chinese scientists on 7 January 2020. |
T10 | 887-1003 | Sentence | denotes | To date, the SARS-CoV-2 virus causing the coronavirus disease (COVID-19) pandemic is spreading throughout the world. |
T11 | 1004-1155 | Sentence | denotes | Here we describe the timeline of events around the first COVID-19 case imported to Finland, and summarise the clinical, molecular and serological data. |
T12 | 1156-1345 | Sentence | denotes | Successful SARS-CoV-2/Finland/1/2020 isolation enabled us to use the cytopathic effect (CPE)-based microneutralisation (MN) assay to detect SARS-CoV-2-specific neutralising antibody levels. |
T13 | 1346-1500 | Sentence | denotes | Diagnostic serum samples of the case and three close contacts were analysed and compared with serum samples from the Finnish population collected in 2019. |
T14 | 1502-1563 | Sentence | denotes | Clinical presentation and laboratory confirmation of the case |
T15 | 1564-1710 | Sentence | denotes | The first COVID-19 case in Finland was a female Chinese tourist in her 30s, who had left Wuhan on 22 January and arrived in Finland on 23 January. |
T16 | 1711-1787 | Sentence | denotes | Her first symptoms were a runny nose on 26 January and nausea on 27 January. |
T17 | 1788-1881 | Sentence | denotes | Because of high fever (39 °C), weakness and cough she sought medical attention on 28 January. |
T18 | 1882-2096 | Sentence | denotes | Suspicion of COVID-19 led to her direct transfer to the Lapland Central Hospital in Rovaniemi, where she was isolated and sampled on 28 and 29 January for laboratory confirmation of SARS-CoV-2 infection (Figure 1). |
T19 | 2097-2315 | Sentence | denotes | SARS-CoV-2 infection was confirmed from nasopharyngeal samples on 29 January by the Helsinki University Hospital Laboratory (HUSLAB), and further confirmed at the Finnish Institute for Health and Welfare (THL) (Table). |
T20 | 2316-2471 | Sentence | denotes | Both laboratories performed real-time RT-PCR testing for three targets: the envelope (E), the RNA-dependent RNA polymerase (RdRp) and the nucleocapsid (N). |
T21 | 2472-2534 | Sentence | denotes | Primers and probes were based on the Corman et al. method [2]. |
T22 | 2535-2597 | Sentence | denotes | Cycle threshold (Ct) values above 37 were considered negative. |
T23 | 2598-2700 | Sentence | denotes | Figure 1 Timeline of events around the first COVID-19 case imported to Finland, January–February 2020 |
T24 | 2701-2731 | Sentence | denotes | COVID-19: coronavirus disease. |
T25 | 2732-2828 | Sentence | denotes | Table Laboratory data of the first case of SARS-CoV-2 infection, Finland, January–February 2020 |
T26 | 2829-2919 | Sentence | denotes | Sampling day Day since the first symptoms Specimen PCR done at E RdRp N MN IgM IgG |
T27 | 2920-2989 | Sentence | denotes | 28 Jan 2020Day 3 NPS HUSTHL ND30.49 ND30.48 ND31.59 NA NA NA |
T28 | 2990-3070 | Sentence | denotes | 29 Jan 2020Day 4 NPA HUSTHL 31.1827.13 27.56 28.43 28.2928.73 NA NA NA |
T29 | 3071-3132 | Sentence | denotes | NPS HUSTHL 28.1529.59 27.1330.87 28.8231.78 NA NA NA |
T30 | 3133-3187 | Sentence | denotes | Serum THLUH NegNeg NegNeg NegNeg < 4 < 20 < 20 |
T31 | 3188-3253 | Sentence | denotes | 03 Feb 2020Day 9 NPS HUSTHL NegNeg NegNeg NegNeg NA NA NA |
T32 | 3254-3289 | Sentence | denotes | Serum UH ND Neg Neg 60 80 80 |
T33 | 3290-3356 | Sentence | denotes | 04 Feb 2020Day 10 NPS HUSTHL NegNeg NegNeg NegNeg NA NA NA |
T34 | 3357-3392 | Sentence | denotes | Serum ND ND ND ND 72 160 160 |
T35 | 3393-3453 | Sentence | denotes | 14 Feb 2020Day 20 Serum UH Neg Neg Neg 160 320 1,280 |
T36 | 3454-3520 | Sentence | denotes | 17 Feb 2020Day 23 NPS HUSTHL NegNeg NegNeg NegNeg NA NA NA |
T37 | 3521-3551 | Sentence | denotes | E: envelope protein gene; HUS: |
T38 | 3552-3884 | Sentence | denotes | Helsinki University Hospital Laboratory; IgG: immunoglobulin G; IgM: immunoglobulin M; MN: microneutralisation test; N: nucleocapsid protein gene; NA: not applicable; ND: not done; Neg: negative; NPA: nasopharyngeal aspirate; NPS: nasopharyngeal swab; RdRp: RNA-dependent RNA polymerase gene; RT-PCR: reverse-transcription PCR; THL: |
T39 | 3885-3930 | Sentence | denotes | Finnish Institute for Health and Welfare; UH: |
T40 | 3931-3954 | Sentence | denotes | University of Helsinki. |
T41 | 3955-4014 | Sentence | denotes | The case had mild symptoms throughout the isolation period. |
T42 | 4015-4143 | Sentence | denotes | She was tested PCR-negative in 3 and 4 February samples and, as considered asymptomatic, discharged from hospital on 5 February. |
T43 | 4144-4233 | Sentence | denotes | One additional sample for serology and PCR was taken on 14 and 17 February, respectively. |
T44 | 4234-4305 | Sentence | denotes | Altogether 21 close contacts were identified of whom we could reach 17. |
T45 | 4306-4374 | Sentence | denotes | Fourteen were still in Finland and placed in quarantine for 14 days. |
T46 | 4375-4516 | Sentence | denotes | Information about three close contacts that had left the country was communicated to the competent authorities in their respective countries. |
T47 | 4517-4582 | Sentence | denotes | For the remaining four close contacts, we had no contact details. |
T48 | 4583-4726 | Sentence | denotes | Two of the 21 close contacts were closely co-exposed and therefore sampled on Days 4, 10, 12 and 14 after the first symptoms of the index case. |
T49 | 4727-4812 | Sentence | denotes | Follow-up of all contacts ended on 11 February without secondary transmission events. |
T50 | 4814-4855 | Sentence | denotes | SARS-CoV-2/Finland/1/2020 virus isolation |
T51 | 4856-5068 | Sentence | denotes | The SARS-CoV-2 virus SARS-CoV-2/Finland/1/2020 was isolated in a biosafety level 3 (BSL-3) laboratory in Vero E6 cells from the Day 4 nasopharyngeal swab (NPS) and nasopharyngeal aspirate (NPA) specimens (Table). |
T52 | 5069-5355 | Sentence | denotes | The samples were inoculated into the cells for 1 h at 37 °C and 5% CO2 and fresh culture medium (Eagle's minimum essential medium (EMEM) supplemented with 2% fetal bovine serum (FBS), 0.6 μg/mL penicillin, 60 μg/mL streptomycin, 2 mM L-glutamine, 20 mM HEPES) were added for incubation. |
T53 | 5356-5509 | Sentence | denotes | On the 4th day of incubation, half of the cultures were blind-passaged onto fresh Vero E6 cells and the rest of original passages were incubated further. |
T54 | 5510-5591 | Sentence | denotes | After 4 days incubation a clear CPE was detected in the NPA-originated passage 2. |
T55 | 5592-5738 | Sentence | denotes | The propagation of stock virus was done by passaging a low virus dose once again in Vero E6 cells, and virus culture was harvested on the 3rd day. |
T56 | 5739-5782 | Sentence | denotes | Virus concentration was followed by RT-PCR. |
T57 | 5783-5989 | Sentence | denotes | The Ct value for virus passage 1 on the 6th day of incubation was 17.65 and for passage 2 on the 2nd day, before any CPE was 20.63, whereas those of the NPS specimen remained at Ct values between 35 and 36. |
T58 | 5991-6040 | Sentence | denotes | SARS-CoV-2/Finland/1/2020 whole-genome sequencing |
T59 | 6041-6295 | Sentence | denotes | Nearly the complete coding region of SARS-CoV-2 (GenBank accession number: MT020781) was sequenced from the NPS collected on Day 4 (Table) and the complete coding region was sequenced from the virus isolate obtained after three passages in Vero E6 cells. |
T60 | 6296-6550 | Sentence | denotes | The virus had 1 nt substitution C21707T compared with the reference strain Wuhan-Hu-1 collected in Wuhan China, December 2019 (NC_045512) [3] which had led to a histidine to tyrosine (H49Y) substitution in the N-terminal domain of the spike glycoprotein. |
T61 | 6552-6601 | Sentence | denotes | Antibody response during the SARS-CoV-2 infection |
T62 | 6602-6719 | Sentence | denotes | Serum samples were collected from the index case on Days 4, 9, 10 and 20 from onset of the first symptoms (Figure 1). |
T63 | 6720-7005 | Sentence | denotes | Presence of serum IgM and IgG antibodies against SARS-CoV-2 was analysed by immunofluorescence assays (IFA) based on Vero E6 cells infected with passage 4 of the patient’s isolate SARS-CoV-2/Finland/1/2020 virus and transferred onto microscope slides and fixed with acetone (Figure 2). |
T64 | 7006-7111 | Sentence | denotes | Serum samples from the index case were serially diluted and incubated for 2 h for IgM and 30 min for IgG. |
T65 | 7112-7222 | Sentence | denotes | Antibodies were visualised with fluorescein isothiocyanate (FITC)-conjugated anti-human IgM or IgG antibodies. |
T66 | 7223-7396 | Sentence | denotes | While the antibodies were undetectable on Day 4 after onset of symptoms, IgG titres rose to 80 and 1,280 and IgM titres to 80 and 320 on Days 9 and 20, respectively (Table). |
T67 | 7397-7546 | Sentence | denotes | Random serum samples from staff members of the University of Helsinki (n = 19) did not show specific binding at dilutions greater than 20 (Figure 2). |
T68 | 7547-7651 | Sentence | denotes | Figure 2 Immunofluorescence assay of serum samples, COVID-19 index case, Finland, January–February 2020 |
T69 | 7652-7687 | Sentence | denotes | COVID-19: coronavirus disease 2019. |
T70 | 7688-7828 | Sentence | denotes | Anti-SARS-CoV-2 IgM and IgG antibodies were detectable by immunofluorescence assay in samples from Days 9, 10 and 20 after onset of illness. |
T71 | 7829-7920 | Sentence | denotes | Both IgM and IgG were found at a titre of 80 on Day 9, titres on Day 20 were 320 and 1,280. |
T72 | 7921-8043 | Sentence | denotes | As an example, dilutions 1:20 and 1:160 from the Day 20 sample are shown for, respectively, IgM and IgG of the index case. |
T73 | 8044-8084 | Sentence | denotes | Dilution 20 shown for the control serum. |
T74 | 8085-8278 | Sentence | denotes | Mock- and SARS-CoV2-infected Vero E6 cells collected on Day 6 post infection were lysed in Laemmli sample buffer, and Western blotting (WB) of lysates was performed as described previously [4]. |
T75 | 8279-8388 | Sentence | denotes | At 1:200 dilution, the convalescent serum on Day 20 identified SARS-CoV2 N, S and E protein bands (Figure 3). |
T76 | 8389-8477 | Sentence | denotes | At higher exposure, all bands were detectable even at 1:1,600 serum dilution (Figure 3). |
T77 | 8478-8641 | Sentence | denotes | Figure 3 Western blot of mock- and SARS-CoV-2 infected Vero E6 cells using patient serum collected 20 days after onset of symptoms, Finland, January–February 2020 |
T78 | 8642-8739 | Sentence | denotes | Top left panel: total protein staining (Ponceau S) of the nitrocellulose membrane before probing. |
T79 | 8740-8833 | Sentence | denotes | Top right panel: strips probed with different dilutions of the patient serum at low exposure. |
T80 | 8834-8917 | Sentence | denotes | Bottom panel: the same membranes individually contrasted for higher band intensity. |
T81 | 8918-9087 | Sentence | denotes | The arrows indicate SARS-CoV-2 proteins, the labelling assumes that the migration of SARS-CoV-2 proteins was similar to that of Vero E6-expressed SARS-CoV proteins [23]. |
T82 | 9088-9172 | Sentence | denotes | The bands migrating at ca 110 and 90 kDa probably represent S1 and S2, respectively. |
T83 | 9173-9230 | Sentence | denotes | Marker M: Precision Plus Dual Colour Standards (Bio-Rad). |
T84 | 9231-9360 | Sentence | denotes | The detection was done using Odyssey Infrared Imaging System (LI-COR) using goat anti-human IR800 conjugate at 1:10,000 dilution. |
T85 | 9361-9476 | Sentence | denotes | SARS-CoV-2-specific neutralising antibody levels were measured in duplicate with the MN test in a BSL-3 laboratory. |
T86 | 9477-9652 | Sentence | denotes | The serum samples were heat-inactivated at 56 °C for 30 min and 2-fold serially diluted starting from 1:4 in EMEM supplemented with 2% of heat-inactivated FBS and antibiotics. |
T87 | 9653-9791 | Sentence | denotes | Fifty plaque‐forming units (PFU) of the SARS-CoV-2/Finland/1/2020 strain were added to the serum dilutions and incubated for 1 h at 37 °C. |
T88 | 9792-9936 | Sentence | denotes | Vero E6 cells (5 × 104/well) were added to the virus–serum mix, and the mixture was incubated in 96-well plates for 4 days at 37 °C with 5% CO2. |
T89 | 9937-9972 | Sentence | denotes | Neutralisation was assessed by CPE. |
T90 | 9973-10125 | Sentence | denotes | The neutralisation endpoint was determined as the 50% endpoint of the serum that inhibited the SARS-CoV-2 infection observed by CPE of inoculated cells. |
T91 | 10126-10243 | Sentence | denotes | Diagnostic serum samples from the index case and her three asymptomatic close contacts were studied with the MN test. |
T92 | 10244-10322 | Sentence | denotes | During the acute phase of infection, no neutralising antibodies were detected. |
T93 | 10323-10449 | Sentence | denotes | The patient seroconverted for neutralising antibodies between Day 4 and 9, with the titre increasing to 160 on Day 20 (Table). |
T94 | 10450-10535 | Sentence | denotes | The serum specimens were confirmed not to be toxic or infective to the cells as such. |
T95 | 10536-10613 | Sentence | denotes | Serum samples taken from the three close contacts tested negative in MN test. |
T96 | 10614-10729 | Sentence | denotes | We also tested serum samples collected in 2019 from 83 Finnish subjects aged 4 to 89 years and all tested negative. |
T97 | 10730-10904 | Sentence | denotes | Sera known to be positive for IgG against human coronavirus OC43 and 229E [5] and rabbit or guinea pig antibody against SARS-CoV N protein [6] could not neutralise the virus. |
T98 | 10906-10923 | Sentence | denotes | Ethical statement |
T99 | 10924-11234 | Sentence | denotes | The investigations were carried out in accordance with the General Data Protection Regulation (Regulation (EU) 2016/679 and Directive 95/46/EC) and the Finnish Personal Data Act (Finlex 523/1999) The Finnish Communicable Diseases Act (Finlex 1227/2016) allows sampling for diagnostic and surveillance purposes. |
T100 | 11235-11428 | Sentence | denotes | The convalescent serum sample was obtained on 14 February through informed consent of the patient and research permits (TYH2018322, TYH2019263) from the Helsinki University Hospital Laboratory. |
T101 | 11429-11489 | Sentence | denotes | Finnish population serum samples were collected during 2019. |
T102 | 11490-11635 | Sentence | denotes | The study protocol was approved by the Ethics Committee of the Department of Medicine, Helsinki University Hospital (Permission 433/13/03/00/15). |
T103 | 11636-11723 | Sentence | denotes | Serum samples of University of Helsinki staff members were used under informed consent. |
T104 | 11725-11735 | Sentence | denotes | Discussion |
T105 | 11736-11864 | Sentence | denotes | In the early phase of the COVID-19 outbreak, confirmed cases outside China were mostly imported among travellers from Wuhan [7]. |
T106 | 11865-11959 | Sentence | denotes | The first case in Finland was detected on 29 January among the first imported cases in Europe. |
T107 | 11960-12081 | Sentence | denotes | The case presented mild symptoms without pneumonia: runny nose, nausea, high fever, cough, muscular weakness and fatigue. |
T108 | 12082-12195 | Sentence | denotes | No secondary transmission events were detected despite active follow-up by the Lapland Hospital district and THL. |
T109 | 12196-12301 | Sentence | denotes | As at 17 March 2020, 358 additional laboratory-confirmed cases of COVID-19 have been detected in Finland. |
T110 | 12302-12442 | Sentence | denotes | Many of them are travel-related (mostly from northern Italy and Austria) but there is also local transmission from the travel-related cases. |
T111 | 12443-12690 | Sentence | denotes | The risk of widespread national community transmission of COVID-19 infection in the European Union, European Economic Area and the United Kingdom in the coming weeks is considered high by the European Centre for Disease Prevention and Control [8]. |
T112 | 12691-12839 | Sentence | denotes | The sequence of the viral genome of the patient was nearly identical to the reference strain from Wuhan, reflecting an early importation from China. |
T113 | 12840-12976 | Sentence | denotes | Later sequence information in Finland (up to 2 March) showed clustering with strains circulating in Italy (see nextstrain.org/ncov) [9]. |
T114 | 12977-13251 | Sentence | denotes | Current guidelines from the World Health Organization for testing COVID-19 recommend collection of both acute and convalescent serum samples from patients for serological testing, which can support the identification of the immune response to a specific viral pathogen [10]. |
T115 | 13252-13389 | Sentence | denotes | The SARS-CoV-2 nucleic acid has been found also in anal swabs and blood [11], however we did not detect it in serum samples in this case. |
T116 | 13390-13488 | Sentence | denotes | As yet, only limited data are available on antibody responses during SARS-CoV-2 infection [11,12]. |
T117 | 13489-13669 | Sentence | denotes | Further studies are needed to better understand the seroprevalence of antibodies to different corona viruses in populations and the role of these antibodies in the risk of disease. |
T118 | 13670-13899 | Sentence | denotes | In accordance with earlier findings [11], we found that both IgM and IgG titres were low or undetectable at on Day 4 (the second day after admission to hospital) yet increasing on Day 9–10, i.e. 5–6 days after the first sampling. |
T119 | 13900-14057 | Sentence | denotes | Using other detection methods beyond IFA as well as recombinant antigens and analysing samples from a larger number of patients will shed more light on this. |
T120 | 14058-14205 | Sentence | denotes | The time of first appearance of anti-SARS-CoV antibodies has ranged from Day 3 to 42 and Day 5 to 47 for IgM and IgG antibodies, respectively [13]. |
T121 | 14206-14395 | Sentence | denotes | The WB of the serum sample collected at convalescence showed a prominent response against the N and S protein, confirming their role as main candidate diagnostic targets for antibody tests. |
T122 | 14396-14501 | Sentence | denotes | However, the patient serum appeared to recognise also the E protein and the processed S1 and S2 proteins. |
T123 | 14502-14646 | Sentence | denotes | Although WB detects mainly linear epitopes, the strong antibody response against the S protein correlated well with the results of the MN assay. |
T124 | 14647-14847 | Sentence | denotes | Monitoring of the binding antibodies is suggested to be a more sensitive method than measuring functional neutralising antibodies for serological detection of human coronavirus (hCoV) infections [14]. |
T125 | 14848-14938 | Sentence | denotes | However, hCoV OC43 and 229E samples can also cross-react with SARS-CoV ELISA testing [15]. |
T126 | 14939-15075 | Sentence | denotes | The SARS-CoV-2 CPE-based MN test using live virus appeared to be very specific, while laborious to conduct requiring a BSL-3 laboratory. |
T127 | 15076-15276 | Sentence | denotes | An increase of at least 4-fold in the neutralising antibodies indicating a positive response was detected at Day 9–10 after the first symptoms and at Day 20, the antibody levels were still increasing. |
T128 | 15277-15441 | Sentence | denotes | Our findings indicate that the MN assay is specific for functional SARS-CoV-2 antibodies and could be applied in surveillance of population immunity for this virus. |
T129 | 15442-15620 | Sentence | denotes | The assay can be used as confirmatory tool for SARS-CoV-2 specificity in the development of more accessible diagnostic tools such as assays based on detecting binding antibodies. |
T130 | 15621-15804 | Sentence | denotes | Previous studies on patients with SARS-CoV infection indicated that the median time for seroconversion was 20 days, by which time 60–75% of patients had IgG against the virus [13,16]. |
T131 | 15805-15998 | Sentence | denotes | That IgM and IgG antibodies were present within 2 weeks from the onset of symptoms in our study suggests that early convalescent patients may be suitable sources of therapeutic antibodies [17]. |
T132 | 15999-16246 | Sentence | denotes | In accordance with our finding, a recent preprint report on patients admitted to hospital with confirmed SARS-CoV-2 infection in China indicated that the median time to seroconversion was 11–14 days, depending on the immunological assay used [18]. |
T133 | 16247-16392 | Sentence | denotes | No neutralising SARS-CoV-2 antibodies were detected in the close contacts nor in the control population samples collected during 2019 in Finland. |
T134 | 16393-16538 | Sentence | denotes | A low prevalence (0.21%) of antibodies against Middle East respiratory syndrome coronavirus was reported in the general population of Qatar [19]. |
T135 | 16539-16788 | Sentence | denotes | A meta-analysis of seroprevalence to SARS-CoV among different human populations yielded an overall low seroprevalence (0.10%), although it was slightly higher (0.23%) among healthcare workers and others who had close contact with SARS patients [20]. |
T136 | 16789-16875 | Sentence | denotes | Binding and neutralising HCoV antibodies were found to be higher in older adults [14]. |
T137 | 16876-17137 | Sentence | denotes | In total 97% and 99% of serum samples from healthy adults had antibodies to HCoV-229E and HCoV-OC43, respectively [21], and 75% and 65% of the children in the age group 2.5–3.5 years were found to be seropositive for, respectively, HCoV-NL63 and HCoV-229E [22]. |
T138 | 17138-17397 | Sentence | denotes | While it has been suggested that the late seroconversion in most SARS patients reduces the value of serological assays during the incubation and initial phases of SARS [13], serological testing is suggested for the confirmation of a SARS CoV-2 infection [11]. |
T139 | 17398-17625 | Sentence | denotes | After understanding better the kinetics, specificity and sensitivity of the assays in development, the serological testing may help contact tracing of clusters and have a role in diagnosing acute and past SARS-CoV-2 infections. |
T140 | 17627-17643 | Sentence | denotes | Acknowledgements |
T141 | 17644-17871 | Sentence | denotes | We gratefully thank Mira Utriainen, Sanna Mäki, Minna Haanpää, Marja-Liisa Ollonen, Johanna Rintamäki, Hanna Valtonen, Riitta Santanen, Katri Keino, Alena Kaijalainen and Johanna Mustajoki for their expert technical assistance. |
T142 | 17872-17979 | Sentence | denotes | Christel Pussinen and Mervi Nosa are thanked for their contribution to Finnish population sera collections. |
T143 | 17980-18076 | Sentence | denotes | We also want to thank the anonymous patient for her help and collaboration throughout the study. |
T144 | 18077-18085 | Sentence | denotes | Funding: |
T145 | 18086-18241 | Sentence | denotes | The study was supported by funds from the Finnish Institute for Health and Welfare (THL), Helsinki University Hospital (HUSLAB) and University of Helsinki. |
T146 | 18242-18384 | Sentence | denotes | The funding organisations had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. |
T147 | 18386-18529 | Sentence | denotes | Conflict of interest: LS is a co-investigator in an unrelated study, for which THL has received research funding from GlaxoSmithKline Vaccines. |
T148 | 18530-18590 | Sentence | denotes | The other authors report no potential conflicts of interest. |
T149 | 18591-18614 | Sentence | denotes | Authors’ contributions: |
T150 | 18615-18678 | Sentence | denotes | All authors attest they meet the ICMJE criteria for authorship. |
T151 | 18679-18766 | Sentence | denotes | All authors have contributed to, seen and approved the final version of the manuscript. |
T152 | 18767-18970 | Sentence | denotes | AH set up and performed MN tests, participated in laboratory confirmation of COVID-19 suspicions, coordinated and participated in the collections of the Finnish population sera, and wrote the manuscript. |
T153 | 18971-19041 | Sentence | denotes | TS performed the whole genome sequencing and genetic characterisation. |
T154 | 19042-19100 | Sentence | denotes | SK and JH performed the IFA and WB analysis, respectively. |
T155 | 19101-19210 | Sentence | denotes | PÖ isolated the virus and was responsible of the SARS-CoV-2 related biosafety level 3 laboratory work at THL. |
T156 | 19211-19297 | Sentence | denotes | MP, MS, TP and JS participated in THL COVID-19 situation monitoring group work of THL. |
T157 | 19298-19367 | Sentence | denotes | SB and MM participated in serological analysis planning group of THL. |
T158 | 19368-19419 | Sentence | denotes | SB contributed in the interpretation of MN results. |
T159 | 19420-19532 | Sentence | denotes | ER set up the real-time RT-PCR method at THL and participated in laboratory confirmation of COVID-19 suspicions. |
T160 | 19533-19596 | Sentence | denotes | AK and TS participated in collection of the convalescent serum. |
T161 | 19597-19665 | Sentence | denotes | AK had a significant role to organising convalescent serum sampling. |
T162 | 19666-19751 | Sentence | denotes | HKK, LM and ML were in charge of primary diagnostic of COVID-19 suspicions in HUSLAB. |
T163 | 19752-19880 | Sentence | denotes | HKK and LM also set up the real-time RT-PCR method at HUSLAB and participated in laboratory sample logistics from HUSLAB to THL. |
T164 | 19881-19940 | Sentence | denotes | MB was responsible for the care of the patient in hospital. |
T165 | 19941-20015 | Sentence | denotes | MJ and LS participated in interviewing the index case and contact tracing. |
T166 | 20016-20199 | Sentence | denotes | OV was responsible for virological and serological studies in HUSLAB and University of Helsinki, participated in the designing of the study and organising convalescent serum sampling. |
T167 | 20200-20379 | Sentence | denotes | NI and CSK were responsible of THL laboratory confirmation of COVID-19 suspicions, participated in COVID-19 situation monitoring group work of THL and laboratory sample logistics. |
T168 | 20380-20503 | Sentence | denotes | CSK was also responsible for the collections of the Finnish population sera and participated in the designing of the study. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 685-694 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T2 | 1737-1747 | Phenotype | denotes | runny nose | http://purl.obolibrary.org/obo/HP_0031417 |
T3 | 1766-1772 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
T4 | 1804-1809 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T5 | 1832-1837 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
T6 | 12001-12010 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T7 | 12012-12022 | Phenotype | denotes | runny nose | http://purl.obolibrary.org/obo/HP_0031417 |
T8 | 12024-12030 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
T9 | 12037-12042 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T10 | 12044-12049 | Phenotype | denotes | cough | http://purl.obolibrary.org/obo/HP_0012735 |
T11 | 12051-12068 | Phenotype | denotes | muscular weakness | http://purl.obolibrary.org/obo/HP_0001324 |
T12 | 12073-12080 | Phenotype | denotes | fatigue | http://purl.obolibrary.org/obo/HP_0012378 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32209163-31992387-29337496 | 2531-2532 | 31992387 | denotes | 2 |
32209163-32015508-29337497 | 6435-6436 | 32015508 | denotes | 3 |
32209163-27355360-29337498 | 8275-8276 | 27355360 | denotes | 4 |
32209163-15450134-29337499 | 9083-9085 | 15450134 | denotes | 23 |
32209163-9466772-29337500 | 10805-10806 | 9466772 | denotes | 5 |
32209163-16227300-29337501 | 10870-10871 | 16227300 | denotes | 6 |
32209163-32046819-29337502 | 11861-11862 | 32046819 | denotes | 7 |
32209163-29790939-29337503 | 12973-12974 | 29790939 | denotes | 9 |
32209163-32065057-29337504 | 13325-13327 | 32065057 | denotes | 11 |
32209163-32065057-29337505 | 13481-13483 | 32065057 | denotes | 11 |
32209163-32064855-29337506 | 13484-13486 | 32064855 | denotes | 12 |
32209163-32065057-29337507 | 13707-13709 | 32065057 | denotes | 11 |
32209163-15031782-29337508 | 14201-14203 | 15031782 | denotes | 13 |
32209163-32073157-29337509 | 14843-14845 | 32073157 | denotes | 14 |
32209163-15583332-29337510 | 14934-14936 | 15583332 | denotes | 15 |
32209163-15031782-29337511 | 15797-15799 | 15031782 | denotes | 13 |
32209163-12781535-29337512 | 15800-15802 | 12781535 | denotes | 16 |
32209163-30906787-29337513 | 16534-16536 | 30906787 | denotes | 19 |
32209163-16490123-29337514 | 16784-16786 | 16490123 | denotes | 20 |
32209163-32073157-29337515 | 16871-16873 | 32073157 | denotes | 14 |
32209163-15897988-29337516 | 16991-16993 | 15897988 | denotes | 21 |
32209163-18495857-29337517 | 17133-17135 | 18495857 | denotes | 22 |
32209163-15031782-29337518 | 17307-17309 | 15031782 | denotes | 13 |
32209163-32065057-29337519 | 17393-17395 | 32065057 | denotes | 11 |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32209163-31992387-29337496 | 2531-2532 | 31992387 | denotes | 2 |
32209163-32015508-29337497 | 6435-6436 | 32015508 | denotes | 3 |
32209163-27355360-29337498 | 8275-8276 | 27355360 | denotes | 4 |
32209163-15450134-29337499 | 9083-9085 | 15450134 | denotes | 23 |
32209163-9466772-29337500 | 10805-10806 | 9466772 | denotes | 5 |
32209163-16227300-29337501 | 10870-10871 | 16227300 | denotes | 6 |
32209163-32046819-29337502 | 11861-11862 | 32046819 | denotes | 7 |
32209163-29790939-29337503 | 12973-12974 | 29790939 | denotes | 9 |
32209163-32065057-29337504 | 13325-13327 | 32065057 | denotes | 11 |
32209163-32065057-29337505 | 13481-13483 | 32065057 | denotes | 11 |
32209163-32064855-29337506 | 13484-13486 | 32064855 | denotes | 12 |
32209163-32065057-29337507 | 13707-13709 | 32065057 | denotes | 11 |
32209163-15031782-29337508 | 14201-14203 | 15031782 | denotes | 13 |
32209163-32073157-29337509 | 14843-14845 | 32073157 | denotes | 14 |
32209163-15583332-29337510 | 14934-14936 | 15583332 | denotes | 15 |
32209163-15031782-29337511 | 15797-15799 | 15031782 | denotes | 13 |
32209163-12781535-29337512 | 15800-15802 | 12781535 | denotes | 16 |
32209163-30906787-29337513 | 16534-16536 | 30906787 | denotes | 19 |
32209163-16490123-29337514 | 16784-16786 | 16490123 | denotes | 20 |
32209163-32073157-29337515 | 16871-16873 | 32073157 | denotes | 14 |
32209163-15897988-29337516 | 16991-16993 | 15897988 | denotes | 21 |
32209163-18495857-29337517 | 17133-17135 | 18495857 | denotes | 22 |
32209163-15031782-29337518 | 17307-17309 | 15031782 | denotes | 13 |
32209163-32065057-29337519 | 17393-17395 | 32065057 | denotes | 11 |